Corvex Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Corvex Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-100,000	Closed	-$625K	–	39
2015 Q4	$625K	Hold	100,000	–	–	0.01%	34
2015 Q3	$584K	Hold	100,000	–	–	0.01%	37
2015 Q2	$827K	Hold	100,000	–	–	0.01%	39
2015 Q1	$824K	Hold	100,000	–	–	0.01%	40
2014 Q4	$687K	Hold	100,000	–	–	0.01%	40
2014 Q3	$540K	Hold	100,000	–	–	0.01%	47
2014 Q2	$637K	Hold	100,000	–	–	0.01%	43
2014 Q1	$806K	Sell	100,000 -625,000	-86%	-$4.87M	0.01%	54
2013 Q4	$4.95M	Buy	+725,000	New	+$3.91M	0.1%	52

Other funds holding ARIA

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Corvex Management's ARIA Position: Q1 2016 in Review

Corvex Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2016, closing a stake of 100,000 shares — an estimated $625K sold.

Corvex Management first reported a position in ARIA in Q4 2013 and held it in 9 quarters. The position peaked at $4.95M in Q4 2013. 162 funds tracked by Wall St. Rank hold ARIA as of Q1 2016.

Corvex Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
Corvex Management sold 100,000 Ariad Pharmaceuticals Inc shares in Q1 2016, an estimated $625K.
Corvex Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 9 quarters.
Corvex Management's Ariad Pharmaceuticals Inc position peaked at $4.95M in Q4 2013.
162 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2016.

Based on Corvex Management's 13F filing for Q1 2016, filed 16 May 2016.